精彩内容7月16日,合肥华润神鹿药业提交了宣郁通经汤颗粒中药3.1类新药上市申请获得CDE承办。宣郁通经汤出自《傅青主女科》卷上,合肥华润神鹿药业为首家报产。近几年,华润医药在中药经典名方领域收获满满,已累计拿下了4个新药,5款新药报产在审。图1:合肥华润神鹿药业最新申报的中药新药来源:CDE官网据悉,宣郁通经汤出自《傅青主女科》卷上,具有补肝血,解肝郁,利肝气,降肝火之功效,主治妇人经前腹疼数日...
Source Link精彩内容7月16日,合肥华润神鹿药业提交了宣郁通经汤颗粒中药3.1类新药上市申请获得CDE承办。宣郁通经汤出自《傅青主女科》卷上,合肥华润神鹿药业为首家报产。近几年,华润医药在中药经典名方领域收获满满,已累计拿下了4个新药,5款新药报产在审。图1:合肥华润神鹿药业最新申报的中药新药来源:CDE官网据悉,宣郁通经汤出自《傅青主女科》卷上,具有补肝血,解肝郁,利肝气,降肝火之功效,主治妇人经前腹疼数日...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.